Building blocks and heteroatom alignments are two determining factors in designing multiple resonance (MR)‐type thermally activated delayed fluorescence (TADF) emitters. Carbazole‐fused MR emitters, represented by CzBN derivatives, and the heteroatom alignments of ν‐DABNA are two star series of MR‐TADF emitters that show impressive performances from the aspects of building blocks and heteroatom alignments, respectively. Herein, a novel CzBN analog, Π‐CzBN, featuring ν‐DABNA heteroatom alignment is developed via facile one‐shot lithium‐free borylation. Π‐CzBN exhibits superior photophysical properties with a photoluminescence quantum yield close to 100 % and narrowband sky blue emission with a full width at half maximum (FWHM) of 16 nm/85 meV. It also gives efficient TADF properties with a small singlet‐triplet energy offset of 40 meV and a fast reverse intersystem crossing rate of 2.9×105 s−1. The optimized OLED using Π‐CzBN as the emitter achieves an exceptional external quantum efficiency of 39.3 % with a low efficiency roll‐off of 20 % at 1000 cd m−2 and a narrowband emission at 495 nm with FWHM of 21 nm/106 meV, making it one of the best reported devices based on MR emitters with comprehensive performance.
Hindered by spectral broadening issues with redshifted emission, long‐wavelength (e.g., maxima beyond 570 nm) multiple resonance (MR) emitters with full width at half maxima (FWHMs) below 20 nm remain absent. Herein, by strategically embedding diverse boron (B)/nitrogen (N) atomic pairs into a polycyclic aromatic hydrocarbon (PAH) skeleton, we propose a hybrid pattern for the construction of a long‐wavelength narrowband MR emitter. The proof‐of‐concept emitter B4N6‐Me realized orange‐red emission with an extremely small FWHM of 19 nm (energy unit: 70 meV), representing the narrowest FWHM among all reported long‐wavelength MR emitters. Theoretical calculations revealed that the cooperation of the applied para B‐π‐N and para B‐π‐B/N‐π‐N patterns is complementary, which gives rise to both narrowband and redshift characteristics. The corresponding organic light‐emitting diode (OLED) employing B4N6‐Me achieved state‐of‐the‐art performance, e.g., a narrowband orange‐red emission with an FWHM of 27 nm (energy unit: 99 meV), an excellent maximum external quantum efficiency (EQE) of 35.8 %, and ultralow efficiency roll‐off (EQE of 28.4 % at 1000 cd m−2). This work provides new insights into the further molecular design and synthesis of long‐wavelength MR emitters.
Building blocks and heteroatom alignments are two determining factors in designing multiple resonance (MR)-type thermally activated delayed fluorescence (TADF) emitters. Carbazole-fused MR emitters, represented by CzBN derivatives, and the heteroatom alignments of ν-DABNA are two star series of MR-TADF emitters that show impressive performances from the aspects of building blocks and heteroatom alignments, respectively. Herein, a novel CzBN analog, Π-CzBN, featuring ν-DABNA heteroatom alignment is developed via facile one-shot lithium-free borylation. Π-CzBN exhibits superior photophysical properties with a photoluminescence quantum yield close to 100 % and narrowband sky blue emission with a full width at half maximum (FWHM) of 16 nm/85 meV. It also gives efficient TADF properties with a small singlet-triplet energy offset of 40 meV and a fast reverse intersystem crossing rate of 2.9 × 10 5 s À 1 . The optimized OLED using Π-CzBN as the emitter achieves an exceptional external quantum efficiency of 39.3 % with a low efficiency roll-off of 20 % at 1000 cd m À 2 and a narrowband emission at 495 nm with FWHM of 21 nm/ 106 meV, making it one of the best reported devices based on MR emitters with comprehensive performance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.